239 related articles for article (PubMed ID: 1498320)
1. Danazol therapy in idiopathic thrombocytopenic purpura: the efficacy of low-medium dose therapy.
Kondo H; Iseki T; Goto S; Takaso T; Ohto M; Okuda K
Int J Hematol; 1992 Jun; 55(3):293-300. PubMed ID: 1498320
[TBL] [Abstract][Full Text] [Related]
2. Treatment of idiopathic thrombocytopenic purpura (ITP) in patients with refractoriness to or with contraindication for corticosteroids and/or splenectomy with immunosuppressive therapy and danazol.
Schiavotto C; Castaman G; Rodeghiero F
Haematologica; 1993; 78(6 Suppl 2):29-34. PubMed ID: 8039755
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy of various treatments in the management of idiopathic thrombocytopenic purpura in the adult].
Llamas P; Busto MJ; Díez JL; Cabrera R; Regidor C; Forés R; Sanjuán I; Briz M; Fernández MN
Sangre (Barc); 1995 Jun; 40(3):181-5. PubMed ID: 7570269
[TBL] [Abstract][Full Text] [Related]
4. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
Braendstrup P; Bjerrum OW; Nielsen OJ; Jensen BA; Clausen NT; Hansen PB; Andersen I; Schmidt K; Andersen TM; Peterslund NA; Birgens HS; Plesner T; Pedersen BB; Hasselbalch HC
Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
[TBL] [Abstract][Full Text] [Related]
5. Danazol therapy for chronic immune-mediated thrombocytopenic purpura in a patient with common variable immunodeficiency.
Saulsbury FT; Bringelsen KA
Am J Pediatr Hematol Oncol; 1991; 13(3):326-9. PubMed ID: 1793160
[TBL] [Abstract][Full Text] [Related]
6. [Effective danazol therapy for a patient with Evans syndrome].
Koike M; Ishiyama T; Saito K; Osawa H; Hashimoto M; Wakabayashi Y; Tsuruoka N
Rinsho Ketsueki; 1993 Feb; 34(2):143-6. PubMed ID: 8492411
[TBL] [Abstract][Full Text] [Related]
7. Danazol for the treatment of idiopathic thrombocytopenic purpura.
Ahn YS; Harrington WJ; Simon SR; Mylvaganam R; Pall LM; So AG
N Engl J Med; 1983 Jun; 308(23):1396-9. PubMed ID: 6682484
[TBL] [Abstract][Full Text] [Related]
8. Danazol in refractory autoimmune thrombocytopenic purpura (ATP). A new therapeutic sequence.
Ambriz-Fernández R; Chávez-Sánchez G; Pizzuto-Chávez J; Morales-Polanco MR; Aviles-Miranda A
Arch Invest Med (Mex); 1985; 16(3):295-304. PubMed ID: 3833096
[No Abstract] [Full Text] [Related]
9. [Effects of maintenance treatment after high-dose intravenous gamma-globulin for idiopathic thrombocytopenic purpura].
Yasunaga K; Kokawa T; Fujitake H; Nomura S; Kageyama T; Ohyabu H; Tatsumi N; Im T; Park K; Kawagoe H
Rinsho Ketsueki; 1991 Sep; 32(9):938-44. PubMed ID: 1719256
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of elderly patients with chronic idiopathic thrombocytopenic purpura].
Hasegawa Y; Nagasawa T; Kojima H; Shibuya A; Ninomiya H; Abe T
Rinsho Ketsueki; 1993 Apr; 34(4):460-4. PubMed ID: 8510334
[TBL] [Abstract][Full Text] [Related]
11. Danazol therapy in patients with chronic idiopathic thrombocytopenic purpura: long-term results.
Maloisel F; Andrès E; Zimmer J; Noel E; Zamfir A; Koumarianou A; Dufour P
Am J Med; 2004 May; 116(9):590-4. PubMed ID: 15093754
[TBL] [Abstract][Full Text] [Related]
12. [Danazol - effective second line therapy in idiopathic thrombocytopenic purpura in children. Three case reports].
Szmydki-Baran A; Adamowicz-Salach A; Gołebiowska-Staroszczyk S
Med Wieku Rozwoj; 2008; 12(4 Pt 2):1130-4. PubMed ID: 19531838
[TBL] [Abstract][Full Text] [Related]
13. Lymphocyte subsets in patients with idiopathic thrombocytopenic purpura during high-dose gamma globulin therapy.
Pogliani EM; Della Volpe A; Casaroli I; Maffe PF; Corneo G
Allergol Immunopathol (Madr); 1991; 19(3):113-6. PubMed ID: 1799168
[TBL] [Abstract][Full Text] [Related]
14. Current management of adult idiopathic thrombocytopenic purpura in practice: a cohort study of 201 patients from a single center.
Zimmer J; Andrès E; Noel E; Koumarianou A; Blicklé JF; Maloisel F
Clin Lab Haematol; 2004 Apr; 26(2):137-42. PubMed ID: 15053808
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of idiopathic thrombocytopenic purpura with danazol].
Ruberto E; Espinola R
Sangre (Barc); 1995 Aug; 40(4):307-10. PubMed ID: 7482120
[TBL] [Abstract][Full Text] [Related]
16. Danazol in chronic idiopathic thrombocytopenic purpura resistant to corticosteroids.
Kotlarek-Haus S; Podolak-Dawidziak M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(6):768-76. PubMed ID: 2453406
[TBL] [Abstract][Full Text] [Related]
17. Idiopathic thrombocytopenic purpura in elderly patients: a study of 47 cases from a single reference center.
Daou S; Federici L; Zimmer J; Maloisel F; Serraj K; Andrès E
Eur J Intern Med; 2008 Oct; 19(6):447-51. PubMed ID: 18848179
[TBL] [Abstract][Full Text] [Related]
18. [Low-dose danazol therapy in idiopathic thrombocytopenic purpura].
Nozaki H; Tanaka K; Yonekura S; Shimizu M; Komatsuda M; Nagao T; Arimori S
Rinsho Ketsueki; 1990 Oct; 31(10):1750-1. PubMed ID: 2255068
[TBL] [Abstract][Full Text] [Related]
19. Use of danazol in the management of chronic idiopathic thrombocytopenic purpura.
Heyd J; Hershko C
Isr J Med Sci; 1985 May; 21(5):418-20. PubMed ID: 4040506
[TBL] [Abstract][Full Text] [Related]
20. [Use of vincristine-loaded blood platelets, danazol and gamma globulin in the treatment of patients with idiopathic thrombocytopenic purpura].
Górski J; Czestochowska E; Tymiński W; Kicińska M
Acta Haematol Pol; 1989; 20(1):65-71. PubMed ID: 2618568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
